news
03-08-2024, 04:22 PM
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move (https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDMvMDgvZW xpLWxpbGx5LWFsemhlaW1lcnMtZHJ1Zy1mZGEtYXBwcm92YWwt ZGVsYXllZC5odG1s0gFXaHR0cHM6Ly93d3cuY25iYy5jb20vYW 1wLzIwMjQvMDMvMDgvZWxpLWxpbGx5LWFsemhlaW1lcnMtZHJ1 Zy1mZGEtYXBwcm92YWwtZGVsYXllZC5odG1s?oc=5) CNBC
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab | Eli Lilly and Company (https://news.google.com/rss/articles/CBMieGh0dHBzOi8vaW52ZXN0b3IubGlsbHkuY29tL25ld3Mtcm VsZWFzZXMvbmV3cy1yZWxlYXNlLWRldGFpbHMvdXMtZm9vZC1h bmQtZHJ1Zy1hZG1pbmlzdHJhdGlvbi1jb252ZW5lLWFkdmlzb3 J5LWNvbW1pdHRlZdIBAA?oc=5) Investors | Eli Lilly and Company
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug (https://news.google.com/rss/articles/CBMikwFodHRwczovL3RoZWhpbGwuY29tL2hvbWVuZXdzL2FwL2 FwLXBvbGl0aWNzL2FwLWZkYS13aWxsLXRha2UtYS1kZWVwZXIt bG9vay1pbnRvLXRoZS1zYWZldHktYW5kLWVmZmVjdGl2ZW5lc3 Mtb2YtbGlsbHktZXhwZXJpbWVudGFsLWFsemhlaW1lcnMtZHJ1 Zy_SAZcBaHR0cHM6Ly90aGVoaWxsLmNvbS9ob21lbmV3cy9hcC 9hcC1wb2xpdGljcy9hcC1mZGEtd2lsbC10YWtlLWEtZGVlcGVy LWxvb2staW50by10aGUtc2FmZXR5LWFuZC1lZmZlY3RpdmVuZX NzLW9mLWxpbGx5LWV4cGVyaW1lbnRhbC1hbHpoZWltZXJzLWRy dWcvYW1wLw?oc=5) The Hill
FDA will conduct more review of Eli Lilly's Alzheimer's drug donanemab - The Washington Post (https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9idX NpbmVzcy8yMDI0LzAzLzA4L2VsaS1saWxseS1hbHpoZWltZXJz LWRvbmFuZW1hYi1mZGEv0gEA?oc=5) The Washington Post
F.D.A. Delays Action on Closely Watched Alzheimer's Drug (https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjQvMDMvMD gvaGVhbHRoL2FsemhlaW1lcnMtZHJ1Zy1kb25hbmVtYWIuaHRt bNIBAA?oc=5) The New York Times
More... (https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDMvMDgvZW xpLWxpbGx5LWFsemhlaW1lcnMtZHJ1Zy1mZGEtYXBwcm92YWwt ZGVsYXllZC5odG1s0gFXaHR0cHM6Ly93d3cuY25iYy5jb20vYW 1wLzIwMjQvMDMvMDgvZWxpLWxpbGx5LWFsemhlaW1lcnMtZHJ1 Zy1mZGEtYXBwcm92YWwtZGVsYXllZC5odG1s?oc=5)
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab | Eli Lilly and Company (https://news.google.com/rss/articles/CBMieGh0dHBzOi8vaW52ZXN0b3IubGlsbHkuY29tL25ld3Mtcm VsZWFzZXMvbmV3cy1yZWxlYXNlLWRldGFpbHMvdXMtZm9vZC1h bmQtZHJ1Zy1hZG1pbmlzdHJhdGlvbi1jb252ZW5lLWFkdmlzb3 J5LWNvbW1pdHRlZdIBAA?oc=5) Investors | Eli Lilly and Company
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug (https://news.google.com/rss/articles/CBMikwFodHRwczovL3RoZWhpbGwuY29tL2hvbWVuZXdzL2FwL2 FwLXBvbGl0aWNzL2FwLWZkYS13aWxsLXRha2UtYS1kZWVwZXIt bG9vay1pbnRvLXRoZS1zYWZldHktYW5kLWVmZmVjdGl2ZW5lc3 Mtb2YtbGlsbHktZXhwZXJpbWVudGFsLWFsemhlaW1lcnMtZHJ1 Zy_SAZcBaHR0cHM6Ly90aGVoaWxsLmNvbS9ob21lbmV3cy9hcC 9hcC1wb2xpdGljcy9hcC1mZGEtd2lsbC10YWtlLWEtZGVlcGVy LWxvb2staW50by10aGUtc2FmZXR5LWFuZC1lZmZlY3RpdmVuZX NzLW9mLWxpbGx5LWV4cGVyaW1lbnRhbC1hbHpoZWltZXJzLWRy dWcvYW1wLw?oc=5) The Hill
FDA will conduct more review of Eli Lilly's Alzheimer's drug donanemab - The Washington Post (https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9idX NpbmVzcy8yMDI0LzAzLzA4L2VsaS1saWxseS1hbHpoZWltZXJz LWRvbmFuZW1hYi1mZGEv0gEA?oc=5) The Washington Post
F.D.A. Delays Action on Closely Watched Alzheimer's Drug (https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjQvMDMvMD gvaGVhbHRoL2FsemhlaW1lcnMtZHJ1Zy1kb25hbmVtYWIuaHRt bNIBAA?oc=5) The New York Times
More... (https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDMvMDgvZW xpLWxpbGx5LWFsemhlaW1lcnMtZHJ1Zy1mZGEtYXBwcm92YWwt ZGVsYXllZC5odG1s0gFXaHR0cHM6Ly93d3cuY25iYy5jb20vYW 1wLzIwMjQvMDMvMDgvZWxpLWxpbGx5LWFsemhlaW1lcnMtZHJ1 Zy1mZGEtYXBwcm92YWwtZGVsYXllZC5odG1s?oc=5)